Gout Therapeutics Market Size, Share, And Growth Report 2032

Gout Therapeutics Market: Size

The global Gout Therapeutics Market size was worth around USD 2.61 billion in 2023 and is predicted to grow to around USD 4.52 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.3% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Gout Therapeutics Market on a global and regional level.

Request Free Sample

Gout Therapeutics Market: Overview

Gout is a type of disease caused by frequent occurrences of acute inflammatory arthritis. The symptoms of this disease include red and itchy skin, swollen joints, and limited movement of the affected body parts. Additionally, due to uric acid crystallization and its deposit in tendons adjacent tissues and joints also leads to gout attack. The human body produces some amount of uric acid when it is broken down into purines. It is caused due to a combination of diet and genetic factor. Usually, a person who consumes large amounts of beer and meat shows or gets affected by the symptoms related to this disease.

Due to changing lifestyle, there has been a rise in the prevalence of gout across the globe that has boosted the gout therapeutics market growth. Rising consumption of alcohol, purine-rich diet, growing kidney diseases and obesity worldwide, and rising consumption of certain type of medication like the diuretics are likely to further boost gout incidence. Moreover, the growing adoption of biologics due to their ability to produce powerful anti-inflammatory action will also contribute to the gout therapeutics market in the future. Various drugs in clinical trials currently are expected to be launched over the forecast period, which will further propel this market. Additionally, new product launches and progressive collaboration between leading companies will positively impact this market. However, patent expiry and strict regulations of various drugs may hinder the gout therapeutics market on a global scale.

Request Free Sample

Gout Therapeutics Market: Segmentation

The study provides a decisive view of the gout therapeutics market by segmenting it based on drug type, disease condition, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

On the basis of drug type, the market includes antihyperuricemic agents, colchicine, non-steroidal anti-inflammatory drugs, corticosteroids, and biologics.

On the basis of disease condition, the gout therapeutics market is bifurcated into acute gout and chronic gout.

By distribution channel, the market comprises hospital pharmacy, online sales, and retail pharmacy.

Gout Therapeutics Market: Report Scope

Gout Therapeutics Market: Regional Analysis

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Europe and North America are leading regions that dominate the gout therapeutics market globally, due to the enhanced pharmaceutical research in these areas. North America is among the leading players in the market for gout therapeutics, due to a rising geriatric population base along with modernized routine disorders. Additionally, the U.S. holds the largest share for gout therapeutics market across entire North America. The Asia Pacific region is likely to witness the highest rate of growth over the forecast period in the gout therapeutics market, owing to the rising regional awareness about the disease.

Gout Therapeutics Market: Competitive Players

Some key players in the global gout therapeutics market include:

• Teijin Pharma
• Takeda Pharmaceutical
• Novartis
• Mylan
• Horizon Pharma
• Teva Pharmaceutical
• Iroko Pharmaceuticals
• Hikma Pharmaceuticals
• Merck

The Global Gout Therapeutics Market is segmented as follows:

Global Gout Therapeutics Market: Drug Type Analysis

• Colchicine
• Antihyperuricemic Agents
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Corticosteroids
• Biologics

Global Gout Therapeutics Market: Disease Condition Analysis

• Acute Gout
• Chronic Gout

Global Gout Therapeutics Market: Distribution Channel Analysis

• Retail Pharmacy
• Hospital Pharmacy
• Online Sales

Global Gout Therapeutics Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa